SC
HCAT icon

Shay Capital’s Health Catalyst HCAT Stock Holding History

Shay Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,000
Closed -$463K – 420
2023
Q4 		$463K Buy
+50,000
New +$409K 0.09% 139
2023
Q1 		– Sell
-60,000
Closed -$638K – 477
2022
Q4 		$638K Buy
+60,000
New +$579K 0.2% 98

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Shay Capital's HCAT Position: Q1 2024 in Review

Shay Capital sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 50,000 shares — an estimated $463K sold.

Shay Capital first reported a position in HCAT in Q4 2022 and held it in 2 quarters. The position peaked at $638K in Q4 2022. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Shay Capital reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Shay Capital sold 50,000 Health Catalyst shares in Q1 2024, an estimated $463K.
  • Shay Capital first reported a position in Health Catalyst in Q4 2022 and held it in 2 quarters.
  • Shay Capital's Health Catalyst position peaked at $638K in Q4 2022.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Shay Capital's 13F filing for Q1 2024, filed 15 May 2024.